Notably, higher levels of plasma soluble ACE2 have been reported in older individuals and men compared to women [59], as well as in comorbidities such as metabolic syndrome, obesity, and hypertension, which are associated with severe COVID-19 [60]. Here, ACE2 is linked to COVID-19.